MX2013009976A - Enhanced bioavailable iodine molecules. - Google Patents
Enhanced bioavailable iodine molecules.Info
- Publication number
- MX2013009976A MX2013009976A MX2013009976A MX2013009976A MX2013009976A MX 2013009976 A MX2013009976 A MX 2013009976A MX 2013009976 A MX2013009976 A MX 2013009976A MX 2013009976 A MX2013009976 A MX 2013009976A MX 2013009976 A MX2013009976 A MX 2013009976A
- Authority
- MX
- Mexico
- Prior art keywords
- iodine
- group
- zinc
- metal
- iron
- Prior art date
Links
- 229910052740 iodine Inorganic materials 0.000 title claims abstract description 69
- 239000011630 iodine Substances 0.000 title claims abstract description 69
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title claims abstract description 67
- 241001465754 Metazoa Species 0.000 claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 230000009469 supplementation Effects 0.000 claims abstract description 17
- 244000144977 poultry Species 0.000 claims abstract description 9
- 235000005911 diet Nutrition 0.000 claims abstract description 8
- 230000037213 diet Effects 0.000 claims abstract description 8
- 244000144972 livestock Species 0.000 claims abstract description 8
- 229940024606 amino acid Drugs 0.000 claims description 34
- 150000001413 amino acids Chemical class 0.000 claims description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 21
- 239000004472 Lysine Substances 0.000 claims description 21
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 21
- 229910052751 metal Inorganic materials 0.000 claims description 21
- 239000002184 metal Substances 0.000 claims description 21
- 229910052725 zinc Inorganic materials 0.000 claims description 21
- 239000011701 zinc Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 229910052742 iron Inorganic materials 0.000 claims description 13
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 11
- 239000000969 carrier Substances 0.000 claims description 11
- 239000003797 essential amino acid Substances 0.000 claims description 11
- 235000020776 essential amino acid Nutrition 0.000 claims description 11
- 229910052748 manganese Inorganic materials 0.000 claims description 11
- 239000011572 manganese Substances 0.000 claims description 11
- -1 amino acid iodide Chemical class 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 229910021645 metal ion Inorganic materials 0.000 claims description 7
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 229930182817 methionine Natural products 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 239000013589 supplement Substances 0.000 claims description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000012876 carrier material Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims 6
- 230000003000 nontoxic effect Effects 0.000 claims 6
- 150000008163 sugars Chemical class 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 150000004696 coordination complex Chemical class 0.000 claims 1
- 239000004151 Calcium iodate Substances 0.000 abstract description 8
- UHWJJLGTKIWIJO-UHFFFAOYSA-L calcium iodate Chemical compound [Ca+2].[O-]I(=O)=O.[O-]I(=O)=O UHWJJLGTKIWIJO-UHFFFAOYSA-L 0.000 abstract description 8
- 235000019390 calcium iodate Nutrition 0.000 abstract description 8
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract description 5
- 235000008206 alpha-amino acids Nutrition 0.000 abstract description 2
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 1
- 150000004694 iodide salts Chemical class 0.000 abstract 1
- 229910001511 metal iodide Inorganic materials 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 31
- 239000000203 mixture Substances 0.000 description 19
- ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 7
- 238000002390 rotary evaporation Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000004767 rumen Anatomy 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 241000282849 Ruminantia Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000002496 iodine Chemical class 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- DDKJKQVNNATMAD-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;zinc Chemical compound [Zn].NCCCC[C@H](N)C(O)=O DDKJKQVNNATMAD-JEDNCBNOSA-N 0.000 description 2
- SOGMDUPYAJRSJA-UHFFFAOYSA-N 2-hydroxy-2-methylbutanethioic s-acid Chemical compound CCC(C)(O)C(S)=O SOGMDUPYAJRSJA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000006047 digesta Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002497 iodine compounds Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003044 randomized block design Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- XXLAQBKBVQBYFN-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;iron Chemical compound [Fe].NCCCC[C@H](N)C(O)=O XXLAQBKBVQBYFN-JEDNCBNOSA-N 0.000 description 1
- FWYCEJKPOQMTCU-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;manganese Chemical compound [Mn].NCCCC[C@H](N)C(O)=O FWYCEJKPOQMTCU-JEDNCBNOSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GIIANEWSGYHSDI-UHFFFAOYSA-N 2-aminoacetyl iodide Chemical compound NCC(I)=O GIIANEWSGYHSDI-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SXWWKEDVWQNOCG-XRIGFGBMSA-N I.I.NCCCC[C@H](N)C(O)=O Chemical class I.I.NCCCC[C@H](N)C(O)=O SXWWKEDVWQNOCG-XRIGFGBMSA-N 0.000 description 1
- 229910021579 Iron(II) iodide Inorganic materials 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- GLXGDSIDFQEZRG-UHFFFAOYSA-N [Ca].[I] Chemical compound [Ca].[I] GLXGDSIDFQEZRG-UHFFFAOYSA-N 0.000 description 1
- SWJBITNFDYHWBU-UHFFFAOYSA-N [I].[I] Chemical compound [I].[I] SWJBITNFDYHWBU-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000003165 abomasum Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PPBAJDRXASKAGH-UHFFFAOYSA-N azane;urea Chemical compound N.NC(N)=O PPBAJDRXASKAGH-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000019625 fat content Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BQZGVMWPHXIKEQ-UHFFFAOYSA-L iron(ii) iodide Chemical compound [Fe+2].[I-].[I-] BQZGVMWPHXIKEQ-UHFFFAOYSA-L 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C19/00—Acyclic saturated compounds containing halogen atoms
- C07C19/07—Acyclic saturated compounds containing halogen atoms containing iodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/76—Metal complexes of amino carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/06—Zinc compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention relates to supplementation of the diets of domesticated animals (livestock and poultry) with iodine in an enhanced bioavailable manner, that is to say the iodine is more available to the animal than when using conventional sources of iodine, such as calcium iodate. The supplementary compound are alpha amino acid metal iodide complexes.
Description
IMPROVED BIODY-AVAILABLE IODINE MOLECULES
BACKGROUND OF THE INVENTION
This invention relates to the supplementation of the diets of domesticated animals (livestock and poultry) with iodine in an improved bioavailable manner, ie the iodine is more available to the animal than when conventional sources of iodine are used, such as iodate of iodine. calcium. The supplemental compound are alpha amino acid iodide metal complexes.
It is well known that domesticated animals
(livestock and poultry) are in need of bioavailable metal or mineral supplements, essential amino acids and are also in need of iodine for healthy animal nutrition.
Iodine is a key component of the hormones produced by the thyroid gland. The thyroid is responsible for the growth, development of the brain and the rate at which animals burn energy. Two of the most common sources of iodine used in animal nutrition and therefore used in supplementing animal diets are calcium iodate (CaI03) and ethylenediamine dihydroiodide (EDDI). A test of the efficiency of the effective metabolization of the iodine source by an animal is to measure the iodine levels in the blood serum after the intake of the nutrient material.
In the animal food industry it is known that insufficient availability of iodine to the animal can result in conditions such as goiters, reproductive failure, weak breed, reduced milk yield, mastitis, abnormal respiration, reduced growth rate and even hairless breeds. The symptoms of traditional iodine toxicity in animals are anorexia, excessive salivation, nasal or ocular discharge, abortion, pneumonia and bone / tendon deformities. In addition, excessive feeding of ethylenediamine dihydroiodide (EDDI) is known to interfere with the metabolism of Vitamin A. The high diet of calcium nitrate, thiocyanate, glucosinolate, perchlorate, rubidium and cobalt interferes with the metabolism of iodine and can increase the iodine requirements. Metal iron for nutrient use reduces the toxicity of iodine, but may also increase the need for iodine requirements.
Therefore, it can be seen that conventionally used iodine sources in animal feed, such as inorganic iodine salts or amine salts all have their unique problems. Therefore, there is a continuing need for the development of unique iodine sources that provide better availability to the animal, that is, higher blood serum levels without simply adding more iodine. The primary objective of the
present invention is to meet this need by providing iodine organic minor mineral metal complexes, particularly with amino acid metal complexes, and much more particularly with naturally occurring amino acids and / or metal essential amino acid complexes.
Lysine is an essential amino acid in the diet of mammals. That is to say, lysine can not be synthesized by mammals at an adequate rate to meet metabolic requirements and therefore must be supplied in the diet. Corn is notoriously low in lysine, and if used for animals in a single grain ration, requires lysine supplementation both to maintain the animal's health and to achieve economic growth of the animal. Protected lysine molecules are a common property objective of U.S. Patent Nos. 7,704,521 and 7,846,471. As explained below, the preferred compounds of the present invention that provide enhanced bioavailability of iodine by providing two iodine ions per molecule and are those made from lysine reacted with a compound such as zinc to make zinc diiodide of lysine (structure I, right away).
The method for achieving the above primary objective as well as others will become apparent from the detailed description of the invention. It is understood that the invention is not
limits by its primary objective and that other advantages of the invention such as efficiency of synthesis, lower cost of iodine, increase of iodine in the level of serum in the blood, that is, bioavailability and cost effectiveness of nutritional supplementation are also all achieved
BRIEF DESCRIPTION OF THE INVENTION
Metal amino acid iodide molecules, preferably metal lysine diiodides having a portion of iodine associated with the metal atom and the second associated with the amine salt are prepared and used to provide improved biodi-available iodine supplementation of animals (livestock and poultry) with resulting increased serum iodine levels in the blood.
DETAILED DESCRIPTION OF THE PREFERRED MODALITIES
In the ruminant animal, the ingested food first passes into the rumen where it is partially broken down by bacterial fermentation. During the rumen fermentation, the rumen microbes use nitrogen from the nitrogen compounds that have degraded to form microbial protein. Nitrogen sources for rumen microbes include degradable protein; rumen and peptides, free amino acids and urea. The microbial protein and the non-degraded food protein go to the abomasum and the small intestine where the hydrochloric acid and the mammalian enzymes degrade the microbial protein and the protein of
food not degraded to free amino acids and short peptides. Amino acids and short peptides are absorbed in the intestine and ruminant animals use amino acids for the synthesis of protein to sustain life, growth, reproduce and produce milk.
Of the twenty or more amino acids used by the animal to synthesize proteins, nine are considered essential. Examples of the essential amino acids include leucine, isoleucine, valine, methionine, threonine, lysine, histidine, phenylalanine and tryptophan. The essential amino acids are those amino acids that are required in quantities that exceed amounts produced by the animal, and must be supplied by microbial protein or non-degraded rumen protein. The amino acids supplied in excess are degraded by the animal and excreted in the form of urea. The process to synthesize the ammonia urea is a process that requires input of energy from the animal. If certain essential amino acids are not proposed in adequate amounts, the animal will be limited in the; amount and type of protein that can produce, in this way limiting the performance of the animal. Therefore, providing the appropriate amounts of essential amino acids maximizes the performance of the animal while increasing the efficiency of energy utilization by the animal.
Lysine and methionine are two of the amino acids
much more limiting essentials when feeding corn-based rations. The results of studies also indicate that the protein content of milk is the most sensitive of the production variables (milk yield, fat-corrected milk, milk protein, milk fat and fat content and milk protein) to alterations in the amino acid content of duodenal digesta. Researchers have determined, by incremental amounts of infusion of the limiting amino acids in the duodenum of lactating dairy cows, that the required contribution of lysine and methionine to the total essential amino acids in the duodenal digesta for maximum milk protein content approached 15 % and 5.2%, respectively.
The present invention relates to certain iodine complexes that provide animal (livestock or poultry) supplementation that provides both the opportunity for essential amino acid supplementation, iodine supplementation and also provides a minor mineral. For the present knowledge of the Applicant, there have been no compounds that have provided, in the past, all of these supplements in the same compound. This is important because often space in a mixture of animal feed is sometimes a problem; and this invention meets three nutritional requirements with a
molecule, with a pure result of improved bioavailability of iodine in blood serum compared to normal sources of iodine, such as EDDI and calcium iodine.
The much more preferred amino acid for use in the present invention is lysine to provide compounds such as zinc lysine diiodide of the formula:
'(Structure I)
As can be seen from Structure I, iodine is provided in this compound in two sources; first, in association with the zinc atom and second in the amine salt form of iodine. In this way there is an opportunity for "double improvement" with this compound. In other words, the structure has both an iodine salt iodine and a iodine metal salt. Structure I for lysine diiodides can be generalized by replacing the zinc atom that represents the metal ion. For the present invention, the suitable metal ions can be manganese and iron in case the generalized formula would be:
(Generalized formula for metal diiodide lysine salts - Structure II)
As mentioned hitherto, lysine is the preferred amino acid but not only the only one that can be employed in the present invention. M can be zinc, manganese or iron. In fact, the invention can be generalized to other naturally occurring amino acids as follows:
In Structure III in the above formula, M represents the metal ion and can be zinc, manganese or iron. R represents any remaining portion of a naturally occurring amino acid and can be selected from the group derived from essential amino acids including leucine, isoleucine, valine, methionine, threonine, lysine, histidine, phenylalanine and tryptophan. The amino acid can also be one of the other 20 or more amino acids used by animals to synthesize proteins and also be a mixture of a variety of amino acids that lead to a mixture of iodine metal salts of amino acids (see Example II below).
It should be noted that in Structure (III) the amino group can be replaced with a hydroxy to form metal complexes of hydroxyl acid with iodine. Put another way to generalize, the amino group of Structure (III) can be replaced with "X", and "X" can be either
amino or hydroxyl. Other possibilities include R is CH3, R is H, R is C2Hs and R is C2H4SCH3, in which case the acid is respectively lactic acid, glycolic acid, hydroxybutyric acid and hydroxy-methylthio-butyric acid (see Example III).
The process for preparing the amino acid metal iodine salts is direct, simply by mixing amounts in an aqueous medium of the amino acid and the source of the metal ion, for example if it is zinc, zinc iodide. It is stirred and heated for a sufficient time to allow the reaction to occur, preferably around 100 ° C for 30-40 minutes. This is followed by cooling to room temperature, drying to leave a solid which, if it is not in powder form, is milled to produce a powder. It can be dried by spraying or drying by rotary evaporation, etc. One of the efficiencies that provides cost effectiveness is the simple methodology for preparation.
The compounds prepared as in the above, and especially those listed as preferred, are easily processable. They can be sold as a supplemental additive or can be mixed with carriers to improve packaging, processability and taste. Preferred carriers are, for example, powdered sugar which significantly improves the taste for ruminants that
they ingest the same. For example, the Benzaldehyde derivatives have an almond flavor which can be masked with powdered sugar.
The compounds can also be used as a part of the total minor mineral supplementation for the animal.
While it is preferred that the compounds of the present invention be added without additional carriers or filler material, as mentioned so far, flavorings can be used as or 1 with the carrier. If carriers are employed, the carrier may be suitable carriers such as soluble fermentation distillers, food grains, corn cob meal, whey or other cellulose carrier materials. They can also be added at the same time or with other minor mineral preparations.
The amount of supplement added to the feed ration will vary, of course, depending on whether the pure compositions or the composition are used with a carrier. Basically the supplement will simply be mixed with the food ration, as it is sold.
Generally the compounds must be added at a level to provide sufficient iodine essential for the performance levels of the animals and daily nutritional needs, that is, within the range of
approximately 25 mg / head / day to approximately 50 milligrams per animal per day for the performance level and 5-10 mg / day for the nutrition level. In this way, the total range of addition is 5mg to 50mg per head per day, depending on the objective.
The following examples are offered to further illustrate but not to limit the compounds of the invention and how to show their use for the effective improvement of iodine supplementation in cattle or poultry at the level of serum in the blood.
EXAMPLE I
Synthesis of Zinc Lysine Diiodide (Structure I)
Lysine (4.24 g, 0.029 mole) was dissolved in water (200 mL). To this solution was added Znl2 (9.26 gr, 0.29 mol). This mixture was stirred and heated at 100 ° C for 35 minutes. This solution was allowed to cool to room temperature and the resulting solution was dried by rotary evaporation resulting in an off-white solid. The material was analyzed for zinc content and iodine content. The percentage of zinc 12.8 and percentage of Iodine 50.5.
EXAMPLE II
Synthesis of Zinc iodide (Amino Acid) (Structure III with mixed amino acids and M = Z)
A mixture of amino acids was prepared by mixing the
following amino acids:
This mixture of amino acids has an average molecular weight of 130.57
10. 2 g of this amino acid mixture (0.078 mol) was dispersed in 250 mL of water and Znl2 (24.9 g, 0.078 mol) was added. This mixture was heated until it was a solution. This solution then heated up! at 100 ° C for 28 minutes. The mixture was cooled to room temperature and the water was stirred by. rotary evaporation. The resulting product had 13.9 percent zinc and 53.2 percent iodine.
EXAMPLE III
(Zinc hydroxy-methylthio-bütiric acid iodide) (Structure III, M = Z and R is methionine)
Hydroxyl methylthio butanoic acid (88% solution) (35.7 g, 0.21 mol) was dissolved in 350 mL of water. TO
this mixture was added Z.nl2 (67 g, 0.21 mol). This mixture was stirred and the pH was adjusted to pH = 3 by the addition of ION NaOH dropwise. The mixture was heated for 1.5 hours at 100 ° C. The resulting mixture was cooled and then dried to a solid by rotary evaporation. This solid was analyzed for 11.9% zinc and 30% iodine.
EXAMPLE IV
(Zinc glycine iodide) (Structure III, M = Zn and glycine)
Glycine (28.6 g, 0.381 mol) was dissolved in 150 mL of water. Znl2 (121.6 g, 0.381 mol) was added to this mixture and the whole solution was stirred and heated at 100 ° C for 45 minutes. The mixture was cooled to room temperature and the solvent was removed by rotary evaporation. The solid is analyzed for zinc and iodine. The dried product is analyzed for 14.3% zinc and 40% iodine.
EXAMPLE V
(Synthesis of Iron Lysine Diiodide)
Lysine (4.76 g, 0.0326 mol) was dissolved in water (100 mL). To this solution was added FeI2 (10.1 gr, 0.0326 moles). This mixture was stirred and heated at 100 ° C for 35 minutes. This solution was allowed to cool to room temperature and the resulting solution was dried by rotary evaporation resulting in a brown solid. He
material was analyzed for iron content and iodine content. Iron percentage 11.7% and percentage of Iodine 53.4%.
EXAMPLE VI
(Synthesis of Manganese Lysine Diiodide)
Lysine was dissolved (4.7 g, (L0323 mol) in water
(lOOmL). To this solution was added Mnl2 (10.1 gr, 0.0323 mol). This mixture was stirred and heated at 100 ° C for 35 minutes. This solution was allowed to cool to room temperature and the resulting solution was dried by rotary evaporation resulting in an off-white solid. The material was analyzed for zinc content and iodine content. Manganese percentage 11.6% and percentage of Iodine 52.1%.
EXAMPLE VII
This example illustrates improved levels of iodine in blood serum, which demonstrate superiority over conventional sources.
EDDI = ethylenediamine dihydroiodide
CaI03 = Calcium Yodate
Pregnant, non-lactating beef cows, Angus Simmental, weighing between 1200 and 1700 lbs were assigned to a study with a "completely randomized block design to determine the effect of novel iodine compounds on the concentration of iodine in
serum as compared to EDDI and CaI03. The cows were blocked in body weight in 7 days before the start of the test. The cows were fed with a bolus containing 60 mg of iodine from the various sources from day 0 to day 10. The serum iodine in the blood was measured and reported as an average of day 2-14 and as a peak value on day 10. Compounds 1 and 2 showed higher levels of iodine in the blood than CaI03 or EDDI.
60 mg of Iodine / day for 10 days
EXAMPLE VI I I
another efficacy test, pregnant, non-lactating, Angus Simmental beef cows, weighing between 1200 and 1700 lbs were assigned to a study with a completely randomized block design to determine the effect of novel iodine compounds as compared with EDDI and CaI03 in serum iodine concentration. The cows were blocked in body weight 7 days before the start of the test.
60 mg of Iodine / day for 10 days
As can be seen from the above examples, the iodine bound to the metal amino acid is producing a much higher iodine blood serum level than the standard materials (EDDI, CaI03), which indicate improved bioavailable iodine levels.
Similar results are achieved if the metal is manganese or iron, and if other naturally occurring amino acids are used, individually or in combination.
Claims (1)
- CLAIMS 1. A method for improving the bioavailability of iodine in livestock and poultry from iodine nutrient sources, characterized in that it comprises: Feed animals with an effective amount of nutritional supplementation of an essential metal amino acid iodide of the formula: wherein M is a metal ion selected from the group consisting of zinc, manganese and iron, and R is a portion selected to provide the backbone of a naturally occurring amino acid to an animal in need of iodine supplementation. 2. The method according to claim 1, characterized in that the effective amount of diet supplementation is an amount sufficient to provide a level of about 5 milligrams per head per day to about 50 milligrams of iodine per head per day. 3. The method according to claim 1, characterized in that the supplement is added in conjunction with non-toxic carriers. 4. The method in accordance with the claim 3, characterized in that the non-toxic carriers are selected from the group consisting of sugars, soluble fermentation materials, food grains, corn cob meal, whey and other cellulose carrier materials. 5. The method according to claim 1, characterized in that the amino acid is an essential amino acid selected from the group consisting of leucine, isoleucine, valine, methionine, threonine, lysine, histidine, phenylalanine and tryptophan. 6. A method for improving the bioavailability of iodine in livestock and poultry from iodine nutrient sources, characterized in that it comprises: Feed animals with an effective amount of nutritional supplementation of a metal lysine diiodide of the formula: wherein M is a metal ion selected from the group consisting of zinc, manganese and iron. 7. The method according to claim 6, characterized in that the effective amount of diet supplementation is an amount sufficient to provide a level of approximately 5 milligrams per head per day to approximately 50 milligrams of iodine per head per day. 8. The method according to claim 6, characterized in that the supplement is added in conjunction with non-toxic carriers. 9. The method according to claim 8, characterized in that the non-toxic carriers are selected from the group consisting of sugars, soluble fermentation materials, food grains, corn cob meal, whey and other carrier materials. of lysine diiodide characterized in that it is a metal ion selected from the group consisting of zinc, manganese and iron. 11. The compound according to claim 10, characterized in that M is zinc. 12. The compound according to claim 10, characterized in that M is manganese. 13. The compound according to claim 10, characterized in that M is iron. 14. Acid hydroxyl metal complexes with iodine of the formula: characterized in that M is a metal selected from the group consisting of zinc, manganese and iron, and R is selected from the group consisting of hydrogen, methyl, ethyl and 2- (methylthio) ethyl. 15. The metal complex according to claim 14, characterized in that R is 2- (methylthio) -ethyl. 16. A method for improving the bioavailability of iodine in livestock and poultry, characterized in that it comprises: Feed animals with an effective amount of nutritional supplementation of hydroxyl metal complex with iodine of the formula: where M is a metal selected from the group consisting of zinc, manganese and iron, and R is selected from the group consisting of hydrogen, methyl, ethyl and 2- (methylthio) ethyl. 17. The method according to claim 16, characterized in that the effective amount of diet supplementation is an amount sufficient to provide a level of approximately 5 milligrams per head per day to approximately 50 milligrams of iodine per head per day. 18. The method according to claim 16, characterized in that the supplement is added in conjunction with non-toxic carriers. 19. The method according to claim 18, characterized in that the non-toxic carriers are selected from the group consisting of sugars, soluble fermentation materials, food grains, corn cob meal, whey and other cellulose carrier materials.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/037,716 US9149057B2 (en) | 2011-03-01 | 2011-03-01 | Enhanced bioavailable iodine molecules |
PCT/US2012/026246 WO2012118688A2 (en) | 2011-03-01 | 2012-02-23 | Enhanced bioavailable iodine molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013009976A true MX2013009976A (en) | 2013-10-17 |
MX350132B MX350132B (en) | 2017-08-28 |
Family
ID=45852699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009976A MX350132B (en) | 2011-03-01 | 2012-02-23 | Enhanced bioavailable iodine molecules. |
Country Status (18)
Country | Link |
---|---|
US (4) | US9149057B2 (en) |
EP (1) | EP2680710B1 (en) |
JP (1) | JP6106610B2 (en) |
KR (1) | KR101548627B1 (en) |
CN (1) | CN103596449B (en) |
AU (1) | AU2012223599B2 (en) |
BR (1) | BR112013022286A2 (en) |
CA (1) | CA2828702C (en) |
CL (1) | CL2013002495A1 (en) |
DK (1) | DK2680710T3 (en) |
ES (1) | ES2651506T3 (en) |
HU (1) | HUE037745T2 (en) |
MX (1) | MX350132B (en) |
NO (1) | NO2680710T3 (en) |
PL (1) | PL2680710T3 (en) |
PT (1) | PT2680710T (en) |
WO (1) | WO2012118688A2 (en) |
ZA (1) | ZA201306537B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9126909B2 (en) * | 2012-12-06 | 2015-09-08 | The United States Of America, As Represented By The Secretary Of Agriculture | Heavy metal remediation via sulfur-modified bio-oils |
CN104853813B (en) * | 2012-12-19 | 2018-07-10 | 高露洁-棕榄公司 | Zinc and amino-acids halide complex and cysteine |
CN108077605A (en) * | 2017-11-17 | 2018-05-29 | 龙岩台迈三略制药有限公司 | A kind of preparation method of ethylenediamine dihydro iodine and its application for feed addictive |
ES2955166T3 (en) * | 2018-12-18 | 2023-11-29 | Phytobiotics Futterzusatzstoffe Gmbh | Production of a lysinate compound from an aqueous lysine solution |
GB201907960D0 (en) * | 2019-06-04 | 2019-07-17 | Nutripharm Ltd | Intraruminal bolus and method of making |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2281612A (en) | 1939-12-12 | 1942-05-05 | Tyler Lab Inc | Iodine compound and method for producting the same |
US2331424A (en) * | 1940-09-19 | 1943-10-12 | Tyler Lab Inc | Iodine compound for animal feeding |
US2385394A (en) * | 1943-04-13 | 1945-09-25 | Tyler Lab Inc | Solid iodine compositions and methods for producing the same |
US4021569A (en) | 1973-08-20 | 1977-05-03 | Zinpro Corporation | Method of nutritional supplementation for zinc and methionine by ingesting 1:1 zinc methionine complexes |
US4039681A (en) | 1973-08-20 | 1977-08-02 | Zinpro Corporation | Zinc methionine complex for acne treatment |
US3950372A (en) | 1974-07-03 | 1976-04-13 | Zinpro Corporation | 1:1 Manganese alpha amino acid complexes |
NZ183858A (en) * | 1976-12-17 | 1979-10-25 | Ashmead Hh | Polyvalent metal proteinates as food additives |
JPH0779633B2 (en) * | 1987-01-07 | 1995-08-30 | 旭化成工業株式会社 | How to raise poultry for meat |
US5061815A (en) * | 1988-07-06 | 1991-10-29 | Zinpro Corporation | Metal lysine complexes and method for producing metal lysine complexes |
US4956188A (en) * | 1988-10-20 | 1990-09-11 | Zinpro Corporation | Copper complexes with alpha hydroxy organic acids and their use as nutritional supplements |
US4900561A (en) | 1989-01-03 | 1990-02-13 | Zinpro Corporation | Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements |
US4948594A (en) | 1989-01-03 | 1990-08-14 | Zinpro Corporation | Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements |
JPH06141712A (en) * | 1991-04-24 | 1994-05-24 | Nobuo Ogura | Iodine-containing vegetable, raised bird and fish |
US5583243A (en) * | 1995-05-19 | 1996-12-10 | Zinpro Corporation | Salts of alpha-hydroxy aliphatic carboxylic acids and uses thereof |
CN1162399C (en) | 2001-04-28 | 2004-08-18 | 曾雄飞 | Amino acid iodine complex |
US7129375B2 (en) * | 2002-10-16 | 2006-10-31 | Zinpro Corporation | Metal complexes of α amino dicarboxylic acids |
CN1480134A (en) * | 2003-07-18 | 2004-03-10 | 曾雄飞 | Amino acid iodine composition and preparation method and application thereof |
US20070053866A1 (en) * | 2005-09-06 | 2007-03-08 | Novus International Inc. | In-can and dry coating antimicrobial compositions having hydroxy analogs of methionine and derivatives |
US7704521B2 (en) | 2007-04-11 | 2010-04-27 | Zinpro Corporation | Rumen protected essential amino acids |
-
2011
- 2011-03-01 US US13/037,716 patent/US9149057B2/en active Active
-
2012
- 2012-02-23 CA CA2828702A patent/CA2828702C/en active Active
- 2012-02-23 DK DK12709418.3T patent/DK2680710T3/en active
- 2012-02-23 ES ES12709418.3T patent/ES2651506T3/en active Active
- 2012-02-23 BR BR112013022286-7A patent/BR112013022286A2/en not_active Application Discontinuation
- 2012-02-23 AU AU2012223599A patent/AU2012223599B2/en active Active
- 2012-02-23 JP JP2013556734A patent/JP6106610B2/en active Active
- 2012-02-23 NO NO12709418A patent/NO2680710T3/no unknown
- 2012-02-23 EP EP12709418.3A patent/EP2680710B1/en active Active
- 2012-02-23 KR KR1020137025808A patent/KR101548627B1/en active IP Right Grant
- 2012-02-23 HU HUE12709418A patent/HUE037745T2/en unknown
- 2012-02-23 PT PT127094183T patent/PT2680710T/en unknown
- 2012-02-23 PL PL12709418T patent/PL2680710T3/en unknown
- 2012-02-23 WO PCT/US2012/026246 patent/WO2012118688A2/en active Application Filing
- 2012-02-23 CN CN201280011401.6A patent/CN103596449B/en active Active
- 2012-02-23 MX MX2013009976A patent/MX350132B/en active IP Right Grant
-
2013
- 2013-04-15 US US13/862,692 patent/US9427001B2/en active Active
- 2013-04-15 US US13/862,678 patent/US9392810B2/en active Active
- 2013-04-15 US US13/862,669 patent/US9144246B2/en active Active
- 2013-08-29 CL CL2013002495A patent/CL2013002495A1/en unknown
- 2013-08-30 ZA ZA2013/06537A patent/ZA201306537B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1556336B1 (en) | Metal complexes of alpha amino dicarboxylic acids | |
US5885610A (en) | By-pass rumen product | |
US9392810B2 (en) | Enhanced bioavailable iodine molecules | |
US7883730B2 (en) | Rumen protected lysine | |
US20090232960A1 (en) | Rumen protected essential amino acids | |
NZ614841B2 (en) | Enhanced bioavailable iodine molecules | |
US10219528B2 (en) | Folic acid, metal complexes for rumen by-pass nutritional supplementation of ruminants | |
US10206415B2 (en) | Folic acid rumen by-pass method and composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |